“Subretinal Gene Therapy Surgery: The Casey Eye Institute Experience”

Approved for 1 CME Credit

Andreas Lauer, M.D. completed his undergraduate training at the University of Rochester followed by medical school and internship at University of Oklahoma Health Sciences Center. He completed ophthalmology residency and vitreoretinal fellowship training at Casey Eye Institute – Oregon Health & Science University. He specializes in the care of patients with medical and surgical diseases of the retina and vitreous. He has served as ophthalmology residency program director, retina fellowship program director and chief of the vitreoretinal division. He has served as investigator in clinical trials in the areas of ocular gene therapy, age-related macular degeneration, inherited retinal diseases, diabetic retinopathy, retinal vein occlusions, and retinopathy of prematurity. Dr. Lauer is recognized internationally as one of the leading ocular gene therapy surgeons. Dr. Lauer serves as a director for the American Board of Ophthalmology and Chair of its Maintenance of Certification program. Dr. Lauer is Chair for the Accreditation Council for Graduate Medical Education Review Committee for Ophthalmology and is a member of the Association of University Professors in Ophthalmology. In 2018, Dr. Lauer was appointed as Chair for the Department of Ophthalmology at OHSU-Casey Eye Institute.